Joanna Strober, a seasoned entrepreneur and former venture capitalist, has secured $60 million in Series B funding for her telehealth platform, Midi Health, aimed at addressing the unique healthcare needs of women in midlife. The investment, led by Emerson Collective with participation from Google Ventures, SteelSky Ventures, and Muse Capital, among others, brings the total funding for Midi Health to $99 million.
Strober’s journey to founding Midi Health began with her personal experience of struggling to obtain a proper diagnosis and treatment for perimenopause symptoms. Recognizing the widespread lack of access to specialized care for women navigating midlife transitions, she embarked on a mission to bridge this gap through telehealth.
Midi Health distinguishes itself from other digital health startups by prioritizing long-term relationships between women and their healthcare providers. Instead of offering quick, one-off solutions, Midi fosters a supportive environment where women feel understood and empowered to address their health concerns comprehensively.
Strober attributes Midi Health’s success to its focus on building a trusted healthcare brand centered on expert care for women. This strategic approach has resonated with investors, even as the broader digital health sector experienced a decline in funding in recent years.
Despite a decrease in digital health investment globally, Midi Health’s Series B funding underscores investor confidence in its mission-driven model. Strober emphasizes the importance of sustaining long-term customer relationships in building a resilient healthcare brand, a philosophy that has guided Midi’s growth trajectory.
The latest funding round will enable Midi Health to expand its telehealth services, particularly in areas related to perimenopause and menopause, such as sexual wellness, hair and skin care, and access to testosterone. By addressing a diverse range of health needs during midlife transitions, Midi aims to enhance the overall well-being of women and empower them to navigate this phase of life with confidence.
Strober emphasizes that perimenopause and menopause represent a substantial market, and Midi Health is committed to continuously evolving its offerings to meet the evolving healthcare needs of women. As the company expands its reach and services, it remains dedicated to providing personalized, expert care that resonates with its growing user base.